Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This is a 48 week study that is intended for HIV Infected persons whose first treatment regimen was with a nonnucleoside reverse transcriptase inhibitor (NNRTI) and who are now failing that regimen. They must be currently on their failing regimen to be eligible.
Epistemonikos ID: 5b97e7caf66e5bc8393acbdaa2ee3258b1d0d2e7
First added on: Mar 22, 2020